171 related articles for article (PubMed ID: 12410513)
1. A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention.
Sutton AG; Ashton VJ; Campbell PG; Price DJ; Hall JA; de Belder MA
Catheter Cardiovasc Interv; 2002 Nov; 57(3):346-52. PubMed ID: 12410513
[TBL] [Abstract][Full Text] [Related]
2. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
Bertrand ME; Esplugas E; Piessens J; Rasch W
Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
[TBL] [Abstract][Full Text] [Related]
4. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
[TBL] [Abstract][Full Text] [Related]
5. Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
Le Feuvre C; Batisse A; Collet JP; Batisse JP; Choussat R; Beygui F; Helft G; Montalescot G; Metzger JP
Catheter Cardiovasc Interv; 2006 Jun; 67(6):852-8. PubMed ID: 16649230
[TBL] [Abstract][Full Text] [Related]
6. Immediate and late adverse reactions in coronary angiography. A comparison between iodixanol and ioxaglate.
Fransson SG; Stenport G; Andersson M
Acta Radiol; 1996 Mar; 37(2):218-22. PubMed ID: 8600966
[TBL] [Abstract][Full Text] [Related]
7. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.
Davidson CJ; Laskey WK; Hermiller JB; Harrison JK; Matthai W; Vlietstra RE; Brinker JA; Kereiakes DJ; Muhlestein JB; Lansky A; Popma JJ; Buchbinder M; Hirshfeld JW
Circulation; 2000 May; 101(18):2172-7. PubMed ID: 10801758
[TBL] [Abstract][Full Text] [Related]
9. Adverse reactions of low osmolar non-ionic and ionic contrast media when used together or separately during percutaneous coronary intervention.
Juergens CP; Khaing AM; McIntyre GJ; Leung DY; Lo ST; Fernandes C; Hopkins AP
Heart Lung Circ; 2005 Sep; 14(3):172-7. PubMed ID: 16352273
[TBL] [Abstract][Full Text] [Related]
10. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
[TBL] [Abstract][Full Text] [Related]
11. The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.
Shah B; Berger JS; Allen N; Guo Y; Sedlis SP; Xu J; Perez A; Attubato M; Slater J; Feit F
Catheter Cardiovasc Interv; 2016 Nov; 88(5):727-737. PubMed ID: 26773574
[TBL] [Abstract][Full Text] [Related]
12. Visipaque (iodixanol) and hexabrix (ioxaglate) in renal insufficiency.
Deray G
J Am Coll Cardiol; 2007 Apr; 49(15):1668. PubMed ID: 17433961
[No Abstract] [Full Text] [Related]
13. Evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in coronary angiography.
Persson P; Liss P; Hansell P
J Am Coll Cardiol; 2007 Apr; 49(15):1668-1669. PubMed ID: 17433962
[No Abstract] [Full Text] [Related]
14. Effects of ionic and nonionic contrast media on endothelium and on arterial thrombus formation.
Barstad RM; Buchmann MS; Hamers MJ; Orning L; Orvim U; Stormorken H; Sakariassen KS
Acta Radiol; 1996 Nov; 37(6):954-61. PubMed ID: 8995473
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty.
Schräder R; Esch I; Ensslen R; Fach WA; Merle H; Scherer D; Sievert H; Spies HF; Zeplin HE
J Am Coll Cardiol; 1999 Feb; 33(2):395-402. PubMed ID: 9973019
[TBL] [Abstract][Full Text] [Related]
16. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml.
Tveit K; Bolz KD; Bolstad B; Haugland T; Berg KJ; Skjaerpe T; Kloster YF
Acta Radiol; 1994 Nov; 35(6):614-8. PubMed ID: 7946687
[TBL] [Abstract][Full Text] [Related]
17. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
18. Impact of anticoagulation on ionic and nonionic contrast media effect on thrombogenesis and fibrinolysis: The PEPCIT study.
Bellemain-Appaix A; Beygui F; Lesty C; Gupta S; Silvain J; Le Feuvre C; Cayla G; Allali Y; Montalescot G; Collet JP
Catheter Cardiovasc Interv; 2012 Apr; 79(5):823-33. PubMed ID: 21618678
[TBL] [Abstract][Full Text] [Related]
19. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
[TBL] [Abstract][Full Text] [Related]
20. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.
Sutton AG; Finn P; Grech ED; Hall JA; Stewart MJ; Davies A; de Belder MA
Am Heart J; 2001 Apr; 141(4):677-83. PubMed ID: 11275937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
